ClinicaliQ Trial Snapshot
- WATER IV Prostate Cancer — Recruiting • Non-phase study • Oncology • NCT06651632.
- This is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, prostatectomy. Participants will be….
- Sponsor: PROCEPT BioRobotics.
Verify eligibility, endpoints and current status on the original source registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, prostatectomy. Participants will be randomized to either Aquablation Therapy or radical prostatectomy and followed up to 10 years.
Eligibility Snapshot
- : 1. Biological male with age ≥ 45 years at the time of consent 2. Biopsy positive Grade Group 1-3 prostate cancer 3. Are candidates for prostatectomy or, in the case of GG1 disease, have already selected a radical therapy as their treatment. 4. Clinical Stage ≤ T2c 5. PSA ≤ 20 ng/ml 6. Prostate volume ≥25 ml
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.